According to the complaint, McKesson raised the prices of over 400 prescription drugs by 25 percent, knowing those stated prices would be relied upon by the state to determine reimbursements for those drugs, according to a Richmond Times-Dispatch report.
Virginia did not participate in the $151 million settlement reached last year between McKesson and 29 states’ Medicaid programs over the same allegations.
“Our office refused to participate in a national settlement led by the Department of Justice because we needed to send a message that Virginia will fight to protect its Medicaid program from fraud and because the original settlement didn’t cover the total loss to our Medicaid program,” said Virginia Attorney General Ken Cuccinelli said in a statement. “This $37 million recovery shows that we will not tolerate Medicaid fraud in Virginia.”
More Articles on Healthcare Lawsuits:
Court Dismisses Class Action Suit Over UCLA Data Breach
St. Luke’s CEO: We’re Trying to Change Healthcare, Not Gain Market Share
CaroMont Health Sues Cogent Healthcare Over Alleged Unfair Practices
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
